176 related articles for article (PubMed ID: 34531504)
1. Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma.
Paone G; Raditchkova-Sarnelli M; Ruberto-Macchi T; Cuzzocrea M; Zucca E; Ceriani L; Giovanella L
Sci Rep; 2021 Sep; 11(1):18496. PubMed ID: 34531504
[TBL] [Abstract][Full Text] [Related]
2. To Enhance or Not to Enhance? The Role of Contrast Medium
Massollo M; Fiz F; Bottoni G; Ugolini M; Paparo F; Puppo C; Provinciali N; Iacozzi M; Altrinetti V; Cistaro A; Cabria M; DeCensi A; Treglia G; Piccardo A
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34206116
[No Abstract] [Full Text] [Related]
3. Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors.
Apitzsch J; Verburg FA; Mottaghy F; Heinzel A
Diagn Interv Radiol; 2021 Jul; 27(4):573-579. PubMed ID: 34313245
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
[TBL] [Abstract][Full Text] [Related]
5. Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?
Brendle CB; Aschoff P; Kratt T; Schraml C; Reimold M; Claussen CD; Pfannenberg CA
Korean J Radiol; 2013; 14(6):951-9. PubMed ID: 24265572
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Contribution of Contrast-Enhanced CT as Compared with Unenhanced Low-Dose CT in PET/CT Staging and Treatment Response Assessment of
Marchetti L; Perrucci L; Pellegrino F; Baroni L; Merlo A; Tilli M; Rambaldi I; Maietti E; Carnevale A; Bartolomei M; Giganti M
J Nucl Med; 2021 Oct; 62(10):1372-1379. PubMed ID: 33712534
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma.
Gómez León N; Delgado-Bolton RC; Del Campo Del Val L; Cabezas B; Arranz R; García M; Cannata J; González Ortega S; Pérez Sáez MÁ; López-Botet B; Rodríguez-Vigil B; Mateo M; Colletti PM; Rubello D; Carreras JL
Clin Nucl Med; 2017 Aug; 42(8):595-602. PubMed ID: 28604477
[TBL] [Abstract][Full Text] [Related]
8. Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CT.
Chiaravalloti A; Danieli R; Caracciolo CR; Travascio L; Cantonetti M; Gallamini A; Guazzaroni M; Orlacchio A; Simonetti G; Schillaci O
Medicine (Baltimore); 2014 Aug; 93(8):e50. PubMed ID: 25121354
[TBL] [Abstract][Full Text] [Related]
9. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?
Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Sakamoto S; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Suganuma N; Sugimura K
Ann Nucl Med; 2011 Aug; 25(7):511-9. PubMed ID: 21670955
[TBL] [Abstract][Full Text] [Related]
10. Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?
Nakamoto Y; Nogami M; Sugihara R; Sugimura K; Senda M; Togashi K
Ann Nucl Med; 2011 Feb; 25(2):93-9. PubMed ID: 20957527
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence.
Kitajima K; Ueno Y; Suzuki K; Kita M; Ebina Y; Yamada H; Senda M; Maeda T; Sugimura K
Eur J Radiol; 2012 Nov; 81(11):3557-62. PubMed ID: 22534465
[TBL] [Abstract][Full Text] [Related]
13. Posttreatment PET/CT Rather Than Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET/CT with Conventional Imaging.
Bakhshi S; Bhethanabhotla S; Kumar R; Agarwal K; Sharma P; Thulkar S; Malhotra A; Dhawan D; Vishnubhatla S
J Nucl Med; 2017 Apr; 58(4):577-583. PubMed ID: 27754902
[TBL] [Abstract][Full Text] [Related]
14. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence.
Kitajima K; Suzuki K; Nakamoto Y; Onishi Y; Sakamoto S; Senda M; Kita M; Sugimura K
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1490-8. PubMed ID: 20386901
[TBL] [Abstract][Full Text] [Related]
15. Follicular Lymphoma Treated with First-Line Immunochemotherapy: A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study.
Barrington SF; Mir F; El-Galaly TC; Knapp A; Nielsen TG; Sahin D; Wenger M; Kostakoglu L; Trotman J; Meignan M
J Nucl Med; 2022 Aug; 63(8):1149-1154. PubMed ID: 34857656
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
Annunziata S; Cuccaro A; Tisi MC; Hohaus S; Rufini V
Ann Nucl Med; 2018 Jun; 32(5):372-377. PubMed ID: 29464479
[TBL] [Abstract][Full Text] [Related]
17. Value of FDG PET/Contrast-Enhanced CT in Initial Staging of Colorectal Cancer - Comparison with Contrast-Enhanced CT.
Kunawudhi A; Sereeborwornthanasak K; Promteangtrong C; Siripongpreeda B; Vanprom S; Chotipanich C
Asian Pac J Cancer Prev; 2016; 17(8):4071-5. PubMed ID: 27644663
[TBL] [Abstract][Full Text] [Related]
18. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT predictive role in follicular lymphoma.
Lopci E; Zanoni L; Chiti A; Fonti C; Santi I; Zinzani PL; Fanti S
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):864-71. PubMed ID: 22354449
[TBL] [Abstract][Full Text] [Related]
20. Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI.
Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Makihara N; Ebina Y; Yamada H; Takahashi S; Sugimura K
Ann Nucl Med; 2014 Jan; 28(1):25-32. PubMed ID: 24129541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
